TY - JOUR
T1 - Vasoactive intestinal peptide receptor expression in chronic periapical lesions
AU - Caviedes-Bucheli, J.
AU - Azuero-Holguín, M. M.
AU - Moreno, G. C.
AU - González, I. L.
AU - Mateu, E.
AU - Salazar, J. F.
AU - Munoz, H. R.
PY - 2007/7
Y1 - 2007/7
N2 - Caviedes-Bucheli J, Azuero-Holguín MM, Moreno GC, González IL, Mateu E, Salazar JF, Munoz HR. Vasoactive intestinal peptide receptor expression in chronic periapical lesions. International Endodontic Journal, 40, 521-525, 2007.AbstractAim To use radioreceptor analysis for evaluating whether vasoactive intestinal peptide (VIP) receptors are present in chronic periapical lesions and to determine whether differences in its expression are found according to the size of the lesions. Methodology Twelve periapical lesions were obtained from teeth diagnosed with chronic apical periodontitis and indicated for endodontic surgery; they were classified according to the size of the lesion in two groups of six samples (lesion size greater or smaller than 5 mm), and then processed and labelled with 125I-VIP. Binding sites were identified by 125I-VIP and standard VIP competition assays. Mann-Whitney's test was used to establish statistically significant differences in the VIP receptor expression between groups. Results Vasoactive intestinal peptide receptor expression was found in all periapical lesion samples. There was a statistically significantly higher expression in periapical lesions <5 mm (P < 0.001). Conclusion Vasoactive intestinal peptide receptors were expressed in chronic periapical lesions with levels inversely proportional to lesion size.
AB - Caviedes-Bucheli J, Azuero-Holguín MM, Moreno GC, González IL, Mateu E, Salazar JF, Munoz HR. Vasoactive intestinal peptide receptor expression in chronic periapical lesions. International Endodontic Journal, 40, 521-525, 2007.AbstractAim To use radioreceptor analysis for evaluating whether vasoactive intestinal peptide (VIP) receptors are present in chronic periapical lesions and to determine whether differences in its expression are found according to the size of the lesions. Methodology Twelve periapical lesions were obtained from teeth diagnosed with chronic apical periodontitis and indicated for endodontic surgery; they were classified according to the size of the lesion in two groups of six samples (lesion size greater or smaller than 5 mm), and then processed and labelled with 125I-VIP. Binding sites were identified by 125I-VIP and standard VIP competition assays. Mann-Whitney's test was used to establish statistically significant differences in the VIP receptor expression between groups. Results Vasoactive intestinal peptide receptor expression was found in all periapical lesion samples. There was a statistically significantly higher expression in periapical lesions <5 mm (P < 0.001). Conclusion Vasoactive intestinal peptide receptors were expressed in chronic periapical lesions with levels inversely proportional to lesion size.
KW - Neuropeptides
KW - Periapical lesion
KW - VIP-receptor
KW - Vasoactive intestinal polypeptide
UR - http://www.scopus.com/inward/record.url?scp=34250020005&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2591.2007.01250.x
DO - 10.1111/j.1365-2591.2007.01250.x
M3 - Article
C2 - 17511789
AN - SCOPUS:34250020005
SN - 0143-2885
VL - 40
SP - 521
EP - 525
JO - International Endodontic Journal
JF - International Endodontic Journal
IS - 7
ER -